https://www.selleckchem.com/products/bmn-673.html
The clinical use of this signature would have improved the detection of EC for earlier therapy and more favorite prognosis. The treatment of oral cancer remains challenging due to its infiltrative nature and a high tendency for tumour relapse leading to an overall poor prognosis. In the case of early recurrence, the patient's prognosis deteriorates dramatically, with survival rate dropping to below 30%. Minimal improvements in survival trends in recurrent and advanced stage tumours have been reported in recent decades. Neoadjuvant immun
Curtir
Comentario
Compartilhar
